摘要
肺炎支原体是儿童社区获得性肺炎的常见病原，随着肺炎支原体感染发病率的攀升，近年来发现其导致的重症肺炎病例也在不断增多，目前重症肺炎支原体肺炎的病因尚不十分明确，而大环内酯类抗生素高耐药率的影响在进一步加重，对该病的治疗提出了新的挑战。该文就重症肺炎支原体肺炎的病因、临床表现、诊断及治疗方面的研究进展作一综述。
Mycoplasma pneumoniae（MP） is a common pathogen of community-acquired pneumonia in children. In recent years, with increase in the incidence of MP infection, the severe cases caused by the later pathogen are also incresing. At present the pathogenesis of severe Mycoplasma pneumoniae pneumonia（SMPP） is still not very explicit, and increased macrolide resistance of MP made a great impact on the treatment. This article reviewed the recent progress in the study of the pathogenesis, clinical manifestations, diagnosis and treatment of SMPP.
出处
《国际儿科学杂志》
2012年第1期92-95,共4页
International Journal of Pediatrics
关键词
肺炎支原体
重症肺炎
儿童
Mycoplasma pneumoniae
Severe pneumonia
Children
